首页> 中文期刊>重庆医学 >SphK1-S1P信号通路的激活参与糖尿病大鼠肾损伤的研究

SphK1-S1P信号通路的激活参与糖尿病大鼠肾损伤的研究

     

摘要

目的观察鞘氨醇激酶1-1-磷酸鞘氨醇(SphK1-S1P)信号通路在链脲佐菌素(STZ)诱导的糖尿病大鼠肾脏中的激活情况。方法观察 STZ诱导的糖尿病大鼠肾脏中 SphK1-S1P信号通路的激活情况。分别检测大鼠肾脏功能及病理指标。采用液质联用分析 SphK1活性及 S1P含量。并采用免疫组织化学、Real-time PCR和 Western blot法检测了 SphK1的表达。结果STZ诱导的糖尿病大鼠血糖、肾重体质量比、24 h尿蛋白显著升高,糖尿病大鼠肾脏系膜区肥大,细胞外基质扩展。同时,糖尿病大鼠肾脏中 SphK1-S1P信号通路被激活,表现为 SphK1表达和活性增加,以及 S1P 生成增加。结论糖尿病大鼠肾脏中存在SphK1-S1P信号通路的激活,可能参与了糖尿病大鼠肾损伤过程。%Objective We aimed to investigate whether SphK1-S1P signaling pathway is activated in diabetic nephropathy.Meth-ods SphK1 activity and S1P levels were measured by LC-MS/MS analysis.The expression of SphK1 were examined by immuno-histochemistry,real-time PCR and Western blot.Results Fasting blood glucose,kidney/body weight ratio and 24-h albuminuria were significantly increased in diabetic mice.Furthermore,mesangial hypertrophy was found in diabetic kidney.Strikingly,the stai-ning,activity and levels of mRNA and protein of SphK1,and S1P production in diabetic kidney were also markedly increased in dia-betic mouse kidney.Conclusion These results demonstrate that the SphK1-S1P signaling pathway is activated in diabetic kidney, suggesting that SphK1-S1P signaling pathway is implicated in the pathogenesis of diabetic nephropathy.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号